Table 1.

Demographics and clinical characteristics of subjects (mean ± SD).

		PD (n=135)	Controls (n=66)
Age		64.0 ± 9.9	62.9 ± 9.5
Men		57%	41%
MDS-UPDRS	Part I score	7.3 ± 4.9
	Part II score	8.8 ± 6.4
	Part III score	26.1 ± 12.8
	Part IV score	2.3 ± 3.5
Hoehn & Yahr		2.0 ± 0.6
PDQ-39 (%)	ADL	16.0 ± 14.4
	Body Discomfort	22.1 ± 21.0
	Cognitive Impairment	15.6 ± 15.4
	Communication	12.8 ± 16.5
	Emotional	12.4 ± 14.8
	Mobility	13.6 ± 17.5
	Social Support	5.2 ± 12.1
	Stigma	15.4 ± 18.8
On any PD medication		89%
On levodopa		63%